AVENOSO, DANIELE
 Distribuzione geografica
Continente #
AS - Asia 1.155
NA - Nord America 894
EU - Europa 538
SA - Sud America 324
AF - Africa 31
Totale 2.942
Nazione #
US - Stati Uniti d'America 839
SG - Singapore 437
IT - Italia 307
CN - Cina 270
BR - Brasile 266
VN - Vietnam 129
HK - Hong Kong 98
BD - Bangladesh 76
FR - Francia 49
TR - Turchia 41
RU - Federazione Russa 39
GB - Regno Unito 32
IN - India 28
AR - Argentina 23
CA - Canada 23
DE - Germania 23
FI - Finlandia 22
MX - Messico 20
IQ - Iraq 16
ES - Italia 12
ID - Indonesia 12
ZA - Sudafrica 12
EC - Ecuador 9
MA - Marocco 8
PL - Polonia 8
SA - Arabia Saudita 8
UA - Ucraina 8
UZ - Uzbekistan 8
PY - Paraguay 7
AL - Albania 6
JP - Giappone 6
NL - Olanda 6
SE - Svezia 6
VE - Venezuela 6
CL - Cile 4
CO - Colombia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PE - Perù 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
AT - Austria 2
BB - Barbados 2
CR - Costa Rica 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 2.942
Città #
Singapore 245
Ashburn 125
Hong Kong 97
New York 77
San Jose 65
Ho Chi Minh City 53
Los Angeles 52
Beijing 50
The Dalles 48
Milan 43
Lauterbourg 40
Dallas 38
Istanbul 32
São Paulo 32
Buffalo 27
Hanoi 27
Des Moines 22
Moscow 22
Brescia 21
Rome 19
Helsinki 17
Santa Clara 17
Council Bluffs 16
Chicago 15
Guangzhou 13
Mexico City 12
Montreal 12
Atlanta 11
Denver 11
Orem 11
Brooklyn 10
Chennai 9
Frankfurt am Main 9
Redondo Beach 9
Turin 9
Brasília 8
Manchester 8
San Francisco 8
Warsaw 8
London 7
Naples 7
Rio de Janeiro 7
Tashkent 7
Baghdad 6
Curitiba 6
Phoenix 6
Stockholm 6
Thái Bình 6
Tokyo 6
Ankara 5
Bologna 5
Bovegno 5
Dhaka 5
Florence 5
Guayaquil 5
Palermo 5
Poplar 5
Toronto 5
Bari 4
Blumenau 4
Catania 4
Falkenstein 4
Haiphong 4
Hangzhou 4
Houston 4
Johannesburg 4
Kyiv 4
Munich 4
Novo Hamburgo 4
Nuremberg 4
Porto Alegre 4
Querétaro 4
Riyadh 4
Seattle 4
Tianjin 4
Tirana 4
Amsterdam 3
Belo Horizonte 3
Birmingham 3
Biên Hòa 3
Bắc Giang 3
Charlotte 3
Da Nang 3
Duhok 3
Duque de Caxias 3
Erbil 3
Figino 3
Fortaleza 3
Goiânia 3
Guarulhos 3
Hefei 3
Itaquaquecetuba 3
Jakarta 3
Kuala Lumpur 3
Montornès del Vallès 3
Mumbai 3
Nova Iguaçu 3
Orlando 3
Padua 3
Paris 3
Totale 1.601
Nome #
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 119
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party 116
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy 103
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 97
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic 89
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 84
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics 83
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study 81
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma 80
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending? 76
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question" 76
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy 75
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation 74
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience 73
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 73
SARS-CoV-2 infection in aplastic anemia 71
A Cellular Therapy with Haploidentical Peripheral Hematopoietic Stem Cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease 69
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 66
Epigenetic Regulation in Myelodysplastic Syndrome as A Consequence of A MicroRNA Dysregulation 64
Case report – Prolonged SARS-CoV-2 positive PCR after resolution of symptoms 63
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 62
ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party 59
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 59
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 58
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report 57
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation 56
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 56
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience 56
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 52
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 51
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 48
Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features 48
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT 48
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease 48
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus" 45
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT 44
Microbial Contamination of Haematopoietic Stem Cell Products: A Single Centre Experience 42
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients 41
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT 39
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 37
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 37
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies 36
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 33
Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 32
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 32
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 31
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia 26
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 26
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm 25
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 24
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 18
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 17
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study 10
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia 6
Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature 4
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study With External Comparison to the Haplo-UK Reduced-Intensity Conditioning Cohort 3
Totale 2.998
Categoria #
all - tutte 10.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 1 0 0 0 0
2023/20244 0 0 0 0 0 1 0 0 2 0 0 1
2024/2025661 0 0 35 92 66 55 89 11 49 35 112 117
2025/20262.332 141 244 142 341 208 171 252 152 188 259 233 1
Totale 2.998